|
JAMA Oncology |
An Intramedullary Enigma |
1 |
Yes |
3/31/2025 |
|
JAMA Oncology |
An Intramedullary Enigma |
1 |
Yes |
3/31/2025 |
|
JAMA Internal Medicine |
An Older Patient With Chest Pain Diagnostic Traps |
1 |
Yes |
9/25/2026 |
|
JAMA Internal Medicine |
An Ominous Wave |
1 |
Yes |
7/29/2027 |
|
American Society of Addiction Medicine |
An Overview of Reimbursement for MAT: Utilizing the Toolkit and Telehealth Updates |
1 |
Yes |
6/3/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
An Unexplained Lost Voice |
1 |
Yes |
2/10/2025 |
|
JAMA Ophthalmology |
An Unusual Case of Severe Bilateral Extraocular Muscle Enlargement |
1 |
Yes |
5/5/2025 |
|
JAMA Internal Medicine |
An Unusual Cause of ST-Segment Elevation in Lead aVR |
1 |
Yes |
2/28/2025 |
|
JAMA Network Open |
Analysis of Attitudes About COVID-19 Contact Tracing and Public Health Guidelines Among Undocumented Immigrants in the US |
1 |
Yes |
12/21/2024 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
|
JAMA Network Open |
Analysis of Vaccine Effectiveness Against COVID-19 and the Emergence of Delta and Other Variants of Concern in Utah |
1 |
Yes |
1/14/2025 |
|
American Medical Association |
Annual Prescription Renewal - Save Time and Improve Medication Adherence |
0.5 |
Yes |
4/25/2025 |
|
JAMA Dermatology |
Annular Erythematous Plaques With Overlying Blisters in a Cluster of Jewels Pattern |
1 |
Yes |
1/24/2027 |
|
JAMA |
Anterior Cruciate Ligament Injuries in Female Athletes |
1 |
Yes |
7/25/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Antibiotic Stewardship Strategies for Adult Outpatient Care |
1 |
Yes |
8/2/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Antibiotic Stewardship Strategies for Adult Outpatient Care |
1.0 |
Yes |
8/2/2026 |
|
JAMA |
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection |
1 |
Yes |
1/14/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
